Myokines are associated with progression, course and mortality in alcohol-associated liver disease.

Autor: Kaur P; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Verma N; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Garg P; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Ralmilay S; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Wadhawan A; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Nadda R; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Prajapati J; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Sharma G; Department of Translational and Regenerative Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Rathi S; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., De A; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Premkumar M; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Taneja S; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India., Singal AK; University of Louisville School of Medicine, Louisville, Kentucky, USA., Duseja A; Department of Hepatology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Jazyk: angličtina
Zdroj: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Oct; Vol. 60 (8), pp. 1005-1020. Date of Electronic Publication: 2024 Aug 12.
DOI: 10.1111/apt.18202
Abstrakt: Background and Aims: Myokines are the muscle-derived hormones orchestrating muscle and systemic health. Their role in the progression of alcohol-associated liver disease (ALD) remains elusive.
Methods: Three-hundred-one patients across the spectrum of ALD including fatty liver (FL, N = 13), compensated cirrhosis (CC, N = 17), non-acute decompensation (NAD, N = 95), acute decompensation (AD, N = 51) and acute-on-chronic liver failure (ACLF, N = 125) were recruited between 2021 and 2023. Plasma myostatin, decorin levels, nutritional status, handgrip strength (HGS), systemic inflammation, infection, ammonia, disease course and 30-day mortality were recorded.
Results: Patients aged 48 years (IQR: 38-52) and 97.7% of males were enrolled. Myostatin was elevated while decorin was reduced in cirrhosis compared to without cirrhosis, and further in DC compared to CC (p < 0.001). A step-wise increase in myostatin and reduction in decorin was observed transitioning from NAD to AD to ACLF (p < 0.001). Myostatin was further increased and decorin was reduced along with the grades and organ failures in AD and ACLF (p < 0.001, each). Baseline decorin (AUC: 0.797) and its combination with MELD (AUC: 0.814) predicted disease resolution in AD and ACLF. Although, both myostatin (aOR: 18.96) and decorin (aOR: 0.02) could predict mortality, decorin was independent (aOR: 0.04) and additive to MELD (AUC of MELD+ log Decorin +  log TLC + HE-grade:0.815); p < 0.05 each. Myostatin increased and decorin reduced with inflammation, hyperammonaemia, malnutrition and HGS in AD and ACLF (p < 0.05, each).
Conclusion: Myokines are linked with malnutrition, fibrosis, systemic inflammation, organ failures, disease course and mortality in ALD. Decorin enhances the risk estimation of mortality of MELD in AD and ACLF. Therapeutic modulation of myokines is a potentially disease-modifying target in ALD.
(© 2024 John Wiley & Sons Ltd.)
Databáze: MEDLINE